PropThink: Positive Analyst Day Comments, Price Targets Rising On SNSS

[ACN Newswire] – By David MoskowitzSunesis Pharmaceuticals (NASDAQ:SNSS) is getting the benefit of a price target increase this morning; Roth Capital raised its price target on the stock from $7.00 to $12.00, after the … more

View todays social media effects on SNSS

View the latest stocks trending across Twitter. Click to view dashboard